Ambulatory hypertensive patients treated by cardiologists in France  by Blacher, Jacques et al.
AC
A
c
L
c
T
F
1
hrchives of Cardiovascular Disease (2013) 106, 86—92
Available  online  at
www.sciencedirect.com
LINICAL RESEARCH
mbulatory  hypertensive  patients  treated  by
ardiologists  in  France
es  hypertendus  soignés  en  cardiologie  libérale  en  France
Jacques  Blachera,∗,  Julie  Peroz-Froza,
Jean-Pierre  Hubermanb,  Marc  Ferrinib,
Gérard  Jullienb,  Maxime  Guenounb,
Dominique  Guedj-Meynierb
a Paris  Descartes  University,  Faculté  de  Médecine,  AP—HP,  Diagnosis  and  Therapeutic  Centre,
Hôtel-Dieu,  Paris,  France
b Collège  National  des  Cardiologues  Franc¸ais,  Paris,  France
Received  4  June  2012;  accepted  13  November  2012
Available  online  11  January  2013
KEYWORDS
Hypertension;
Blood  pressure
control;
Patient  compliance;
Independent  practice
Summary
Background.  —  While  general  practitioners  treat  most  hypertensive  patients  in  France,  hyper-
tension  is  the  most  frequent  pathology  treated  by  cardiologists,  raising  questions  about  the
differing  proﬁles  of  such  patients.  Poor  control  of  hypertension  is  commonly  reported,  and
yet has  not  improved  over  time.  Better  understanding  of  the  determinants  of  control,  at  both
patient and  physician  levels,  is  necessary  to  implement  improvements  in  practice.
Aims. —  To  describe  the  hypertensive  population  treated  by  independent  cardiologists  in  France
and to  assess  the  prevalence  and  determinants  of  not-at-goal  blood  pressure  (BP),  at  patient
and physician  levels.
Methods.  —  The  COLHYGE  study  was  an  observational  cross-sectional  epidemiological  study.
Consecutive  patients  (n  =  5798)  were  selected  by  371  independent  cardiologists  in  France.  Data
concerning  patients  and  physicians  were  assessed.
Results.  —  Our  study  population  had  an  elevated  cardiovascular  risk,  high  prevalence  of  patients
in secondary  cardiovascular  prevention  (27.5%)  and  a  high  proportion  of  diabetic  patients
(22.8%). Only  20.8%  of  the  population  presented  controlled  BP.  At  the  patient  level,  the  following
variables were  negatively  and  independently  associated  with  BP  control:  age;  body  mass  index;
Abbreviations: CNCF, Collège national des cardiologues franc¸ais; COLHYGE, assoCiatiOns thérapeutiques chez L’HYpertendu suivi en
ardioloGie ambulatoirE.
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heart  rate;  recently  diagnosed  hypertension;  left  ventricular  hypertrophy;  patient  belief  that
they are  taking  too  many  pills;  prescription  of  calcium  channel  blockers,  lipid-lowering  agents
and antiplatelet  agents.  Presence  of  atrial  ﬁbrillation  and  the  prescription  of  renin-angiotensin
system blockers  and  ﬁxed  combinations  correlated  positively  with  BP  control.  At  the  physi-
cian level,  working  in  big  cities  and  having  an  exclusive  independent  practice  were  associated
with good  BP  control.  There  was  high  heterogeneity  among  physicians  in  terms  of  BP  control,
independent  of  the  patient  and  physician  characteristics  assessed.
Conclusion.  —  The  COLHYGE  study  has  conﬁrmed  a  high  cardiovascular  risk  and  poor  BP  control
among hypertensive  patients  treated  by  cardiologists  in  France.  Strategies  aiming  to  control  BP
should focus  on  both  patient  and  physician  characteristics.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
MOTS  CLÉS
Hypertension
artérielle  ;
Contrôle  tensionnel  ;
Observance  ;
Pratique  libérale
Résumé
Contexte.  — L’hypertension  artérielle  est  majoritairement  prise  en  charge  en  médecine
générale en  France  ;  elle  représente  néanmoins  la  première  pathologie  traitée  en  cardiolo-
gie libérale  en  France.  Se  pose  donc  la  question  des  caractéristiques  des  hypertendus  pris  en
charge en  cardiologie  libérale  :  sont-ils  majoritairement  à  risque  cardiovasculaire  élevé  ? Par
ailleurs, les  différentes  études  d’observation  réalisées  en  population  continuent  de  rapporter
de faibles  proportions  d’hypertendus  à  l’objectif  tensionnel,  rendant  nécessaire  la  meilleure
connaissance  des  déterminants  du  contrôle  tensionnel,  tenant  compte  des  caractéristiques,  à
la fois  des  patients,  et  des  médecins.
Objectifs.  —  Nos  objectifs  étaient  de  décrire  la  population  hypertendue  traitée  par  des  cardi-
ologues libéraux  en  France  et  d’évaluer  la  prévalence  et  les  déterminants,  liés  à  la  fois  aux
patients et  aux  médecins,  de  l’absence  de  contrôle  tensionnel.
Méthodes.  —  L’étude  COLHYGE  est  une  étude  épidémiologique  d’observation  transversale.  Les
patients consécutifs  (n  =  5798)  ont  été  sélectionnés  par  371  cardiologues  libéraux  en  France.
Résultats.  — Notre  population  d’étude  présentait  un  niveau  de  risque  cardiovasculaire  élevé,
en relation  avec  une  prévalence  élevée  de  patients  en  prévention  secondaire  (27,5  %),  et  de
diabétiques  (23,0  %).  Seulement  20,8  %  de  la  population  présentait  une  pression  artérielle  con-
trôlée. Au  niveau  des  patients,  ont  été  négativement  et  indépendamment  associés  au  mauvais
contrôle tensionnel  :  l’âge,  l’indice  de  masse  corporelle,  le  rythme  cardiaque,  l’hypertension
récemment  diagnostiquée,  la  présence  d’une  hypertrophie  ventriculaire  gauche,  la  sensation  du
patient de  prendre  trop  de  comprimés,  la  prescription  d’inhibiteurs  calciques,  les  hypolipémi-
ants et  antiplaquettaires,  ainsi  que  la  présence  d’une  ﬁbrillation  auriculaire.  En  revanche,
la prescription  des  inhibiteurs  du  système  rénine-angiotensine-aldostérone  et  la  prescription
de combinaisons  ﬁxes  ont  été  corrélées  positivement  au  contrôle  tensionnel.  Au  niveau  des
médecins,  deux  caractéristiques  ont  été  associées  à  un  bon  contrôle  :  travailler  dans  les  grandes
villes, et  avoir  une  pratique  libérale  exclusive.  Il  y  avait  une  très  forte  hétérogénéité  des
médecins,  en  termes  de  contrôle  tensionnel.
Conclusion.  —  L’étude  COLHYGE  a  conﬁrmé  le  haut  risque  cardiovasculaire  et  le  mauvais
contrôle des  hypertendus  traités  par  des  cardiologues  en  France.  Les  stratégies  visant
l’optimisation  du  contrôle  tensionnel  devrait  concerner  patients  et  prescripteurs.
© 2012  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Most  hypertensive  patients  in  France  are  medically  treated
by  their  general  practitioners  [1],  whereas  hypertension
is  the  most  frequent  pathology  treated  by  cardiologists  in
France  (unpublished  data).  This  apparent  paradigm  could  be
related  to  the  different  proﬁles  being  treated  by  different
practitioners,  raising  the  question,  do  French  cardiologists
speciﬁcally  treat  hypertensive  patients  at  high  cardiovascu-
lar  risk?Many  studies  report  poor  hypertension  control  in  popula-
tions  in  France  [2]  and  elsewhere  [3],  but  the  rate  of  con-
trolled  hypertensives  hardly  increases  —  even  after  the  diag-
nosis  of  poor  control  has  been  made  —  and  it  remains  at  a  low
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tevel  today.  It  seems,  then,  important  to  better  understand
he  determinants  of  this  absence  of  control,  at  both  patient
nd  physician  levels,  to  set  up  efﬁcient  corrective  measures.
In  France,  most  cardiologists  are  independent  and  are
embers  of  the  professional  association  of  French  cardio-
ogists  (Collège  National  des  Cardiologues  Franc¸ais [CNCF])
personal  data).  In  2009,  we  had  the  opportunity,  under  the
uspices  of  the  CNCF,  to  design  an  epidemiological  study
ocusing  on  these  topics.  The  objectives  of  the  present  study
ere  to  describe  the  hypertensive  population  treated  by  car-
iologists  in  France  (primary  objective)  and  to  assess  the
revalence  and  determinants  of  not-at-goal  blood  pressure
BP),  at  both  patient  and  physician  levels  (secondary  objec-
ives).
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opulation
he  assoCiatiOns  thérapeutiques  chez  L’HYpertendu  suivi
n  cardioloGie  ambulatoirE  (COLHYGE)  study  was  an  obser-
ational  cross-sectional  epidemiological  study  that  took
lace  in  France  during  2009.  Participation  in  this  study  was
roposed  to  a  representative  panel  of  2983  cardiologists,
ho  were  members  of  the  professional  association  of  the
rench  cardiologists  (CNCF).  This  panel  represents  almost
0%  of  all  independent  French  cardiologists  (n  =  3766).  As
he  COLHYGE  study  was  based  on  voluntary  participa-
ion,  only  516  cardiologists  agreed  to  participate  and  371
ere  truly  active  and  included  patients.  The  panel  of  371
ctive  cardiologists  had  the  following  characteristics:  24
7%)  were  <  40  years,132  (35%)  were  between  40  and  50
ears  and  215  (58%)  were  >  50  years;  83  (22%)  cardiolo-
ists  had  been  in  practice  for  <  10  years  and  288  (78%)
or  ≥  10  years;  81  (22%)  worked  in  rural  areas  or  small  towns
ith  <  20,000  inhabitants,  143  (39%)  worked  in  medium-sized
owns  (20,000—100,000  inhabitants)  and  147  (40%)  worked  in
ig  cities  with  >  100,000  inhabitants;  214  (58%)  had  no  asso-
iated  professional  activities  and  157  (42%)  were  part-time
mployees  (mostly  in  public  hospitals  or  private  clinics);
62  (44%)  worked  on  their  own  and  209  (56%)  worked  in
ssociation  with  other  physicians.  Although  not  selected  ran-
omly,  this  panel  of  371  cardiologists  was  representative  of
he  French  cardiologist  population  concerning  these  charac-
eristics.
Each  physician  was  asked  to  include  all  the  patients
dentiﬁed  from  their  practice  who  fulﬁlled  the  inclusion
riteria,  over  a  limited  period.  As  the  main  objective
as  to  describe  the  hypertensive  population  consulting  a
ardiologist  in  France,  the  inclusion  criteria  were  broad:
ssential  hypertensive  patient;  pharmacologically  treated;
illing  to  participate  in  the  study  and  to  give  consent
fter  provision  of  written  and  verbal  information.  Finally,
798  consecutive  patients  were  included  in  the  study  (mean
umber  of  patients  per  cardiologist  with  all  data  com-
leted  was  15.6  ±  7.9).  The  protocol  was  approved  by
nstitutional  review  committees  (Conseil  National  de  l’Ordre
es  Médecins,  Comité  Consultatif  sur  le  Traitement  de
’Information  en  Matière  de  Recherche  dans  le  domaine  de
a  Santé,  Commission  Nationale  Informatique  et  Liberté).
For  the  patients,  an  inclusion  questionnaire  (completed
y  the  physicians)  contained  the  following  data:  sex;
ge;  body  weight;  height;  body  mass  index;  hyperten-
ion  duration;  history  of  diabetes  mellitus,  dyslipidaemia,
ephropathy,  left  ventricular  hypertrophy,  coronary  heart
isease,  peripheral  artery  disease,  stroke  and  atrial  ﬁbrilla-
ion;  current  smoking  habit;  and  current  use  of  antiplatelet,
ipid-lowering  and  antidiabetic  drugs.  The  antihypertensive
reatment  of  the  patients  was  detailed,  in  terms  of  number
f  antihypertensive  drugs,  use  of  different  antihypertensive
lasses  and  use  of  ﬁxed  combinations,  as  well  as  previous
dverse  effects  related  to  antihypertensive  drugs.
BP  and  heart  rate  were  measured  after  a  5-minute  rest.
ifferent  devices  were  used  — according  to  the  device  gen-
rally  used  by  the  practitioner  (mostly  electronic  devices)
 and  the  mean  of  three  determinations  was  used  for
ystolic  and  diastolic  BP.  Pulse  pressure  was  calculated
i
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s systolic  minus  diastolic.  Mean  BP  was  diastolic  plus  a
hird  of  pulse  pressure.  According  to  the  2007  European
ociety  of  Hypertension  Guidelines  [4],  based  on  these
easurements  and  on  questionnaires,  BP  was  considered
ontrolled  if  systolic  and  diastolic  BPs  were  <  140/90  mmHg
or  patients  without  any  associated  high  cardiovascular
isk  condition  and  <  130/80  mmHg  for  patients  with  dia-
etes  mellitus  or  previous  atherothrombotic  cardiovascular
isease  or  nephropathy  deﬁned  by  either  microalbumin-
ria  (30—300  mg/day  or  20—200  mg/L),  macroalbuminuria
>  300  mg/day  or  >  200  mg/L)  or  renal  failure  deﬁned  by  a
reatinine  clearance  <  60  mL/min.
tatistical analysis
uantitative  variables  were  described  using  means  and
tandard  deviations;  qualitative  variables  were  described  by
umbers  and  percentages.  The  dependent  variable  analysed
as  uncontrolled  BP,  according  to  the  2007  European  Society
f  Hypertension  Guidelines  [4].  First,  each  variable  (patient-
nd  physician-related)  was  tested  in  association  with  this
ependent  variable  in  a  bivariate  logistic  regression  anal-
sis;  second,  a  linear  multilevel  mixed  logistic  model  was
erformed  with  all  statistically  signiﬁcant  variables  in  the
ivariate  analysis  (plus  age,  sex  and  body  mass  index)  using
 backward  manual  selection  procedure,  considering  P  >  0.05
s  the  exit  cut-off  level.  Some  variables,  such  as  mean
rterial  pressure  and  pulse  pressure,  were  excluded  from
he  model  because  of  too  strong  an  intercorrelation  with
ncontrolled  BP.  As  age,  sex  and  body  mass  index  are  well-
ccepted  determinants  of  BP  control,  those  three  variables
ere  forced  in  the  ﬁnal  model.  Two  levels  of  ﬁxed  effects
ere  considered:  the  patient  level  (level  1)  and  the  physi-
ian  level  (level  2).  As  the  presence  of  nephropathy  was
ssessed  in  only  3029  patients,  this  variable  was  not  included
n  the  multivariable  analysis.  All  analyses  were  performed
sing  SAS  software,  version  8.2  (SAS  Institute,  Cary,  NC,
SA).
esults
he  clinical  characteristics  of  the  5798  subjects  included  in
he  COLHYGE  study  are  shown  in  Table  1.  It  is  important
o  note  that  several  characteristics  are  associated  with  an
ncreased  cardiovascular  risk,  namely  the  mean  age  of  66.5
ears,  the  high  proportion  of  men  (55.9%),  the  long  duration
f  hypertension  (36.3%  >  10  years),  the  high  prevalence  of
atients  in  secondary  cardiovascular  prevention  (27.5%),  the
igh  prevalence  of  patients  with  atrial  ﬁbrillation  (17.4%)
nd  the  high  proportion  of  diabetic  patients  (22.8%).
Table  2  shows  that  the  most  frequent  antihypertensive
rugs  prescribed  in  this  population  were  calcium  channel
lockers  (50.2%),  followed  by  diuretics  (48.3%)  and  beta-
lockers  (42.7%),  in  accordance  with  the  high  prevalence
f  patients  with  coronary  heart  disease  (17.4%).  As  previ-
usly  reported,  angiotensin  receptor  blockers  were  more
requently  prescribed  than  angiotensin-converting  enzyme
nhibitors  in  France.  The  mean  number  of  antihyperten-
ive  drugs  per  patient  was  2.1  ±  1.1,  with  an  important
se  of  ﬁxed  combinations  (34.6%).  A  high  proportion  of
atients  (16.3%)  experienced  an  adverse  effect  related  to  an
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Table  1  Clinical  characteristics  of  the  5798  subjects
included  in  the  COLHYGE  study.
Variables
Age  (years) 66.5  ±  12
Body  mass  index  (kg/m2)  27.6  ±  4.7
Male  sex  3237  (55.9)
Hypertension  duration
<  1  year  638  (11)
1  to  5  years 1584  (27.3)
6  to  10  years 1469  (25.4)
>  10  years 2102  (36.3)
Systolic  blood  pressure  (mmHg) 147.1  ±  18.3
Diastolic  blood  pressure  (mmHg)  83.5  ±  10.6
Pulse  pressure  (mmHg)  63.6  ±  14.9
Mean  blood  pressure  (mmHg)  104.7  ±  11.8
Heart  rate  (bpm)  69.6  ±  11.8
Associated  cardiovascular  disease  2402  (41.4)
Coronary  heart  disease  1011  (17.4)
Peripheral  artery  disease  559  (9.6)
Stroke  408  (7.0)
Atrial  ﬁbrillation  1006  (17.4)
Patients  in  secondary  cardiovascular
prevention
1595  (27.5)
Associated  cardiovascular  risk  factors
Current  smokers  752  (13.0)
Diabetes  mellitus  1324  (22.8)
Hypercholesterolaemia  2099  (39.6)
Target  organ  damage
Nephropathy* 688  (11.9)
Left  ventricular  hypertrophy† 447  (9.2)
Data are mean ± standard deviation or number (%). bpm: beats
per minute; COLHYGE: assoCiatiOns thérapeutiques chez
L’HYpertendu suivi en cardioloGie ambulatoirE.
* Presence of nephropathy was available in only 3029 patients.
† Presence of left ventricular hypertrophy was available in only
5399 patients.
Table  2  Therapeutic  characteristics  of  the  5798  sub-
jects  included  in  the  COLHYGE  study.
Variables
Mean  number  of  antihypertensive  drugs
per  patient
2.1 ±  1.1
Calcium  channel  blockers  2908  (50.2)
Diuretics  2803  (48.3)
Beta-blockers  2478  (42.7)
Angiotensin  receptor  blockers 2139  (36.9)
Angiotensin-converting  enzyme  inhibitors 1319  (22.7)
Centrally-acting  agents 419  (7.2)
Antihypertensive  ﬁxed  combination 1917  (34.6)
Previous  adverse  effect  related  to
antihypertensive  drug
941  (16.3)
Other  cardiovascular  medications  3947  (68.1)
Antiplatelet  agents  2040  (35.2)
Lipid-lowering  agents  2884  (49.7)
Antidiabetic  drugs  1324  (22.8)
Patient  belief  that  they  are  taking  too
many  pills
969 (16.9)
Blood  pressure  at  target
< 140/90  for  all  1871  (32.3)
<  130/80  for  high-risk
patientsa,  <  140/90  for  others
1205  (20.8)
Data are mean ± standard deviation or number (%).
a Patients with diabetes mellitus or nephropathy or in secondary
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to  treatment.  Furthermore,  independent  of  patient  char-antihypertensive  drug.  Finally,  only  20.8%  of  the  population
presented  controlled  BP,  as  deﬁned  in  the  2007  European
Society  of  Hypertension  guidelines  [4].  If  140/90  mmHg  was
considered  as  the  goal  for  all,  the  proportion  of  controlled
patients  increased  to  32.3%.
In  Table  3  are  listed  the  independent  determinants  of
non-controlled  BP.  At  the  patient  level,  those  negatively
associated  with  BP  control  were:  age;  body  mass  index;
heart  rate;  recently  diagnosed  hypertension;  the  presence
of  left  ventricular  hypertrophy;  and  patient  belief  that  they
are  taking  too  many  pills.  The  presence  of  atrial  ﬁbrilla-
tion  was  positively  associated  with  BP  control.  Concerning
pharmacological  treatment,  the  prescription  of  calcium
channel  blockers,  centrally-acting  agents,  lipid-lowering
agents  and  antiplatelet  agents  was  negatively  associated
with  BP  control.  On  the  other  hand,  the  prescription  of
a
p
tcardiovascular prevention.
enin-angiotensin  system  blockers  and  ﬁxed  combinations
as  associated  with  controlled  hypertension.  Finally,  two
hysician  characteristics  were  associated  with  poor  con-
rol:  working  in  rural  areas  or  in  small  towns  with  fewer
han  100,000  inhabitants;  and  being  a  part-time  employee  in
omparison  with  having  an  exclusive  independent  practice.
Characteristics  of  the  linear  logistic  multilevel  model
re  shown  in  Table  4.  The  high  variability  of  odds  ratios
hows  the  high  variability  among  the  physicians  in  terms
f  BP  control,  independent  of  patient  characteristics.  The
igh  intraclass  correlation  shows  that  a  high  part  of  the
odel  (15%  of  its  variance)  is  explained  by  physician
haracteristics  that  were  not  taken  into  account  in  the
hysician  questionnaire  (after  adjustment  for  all  assessed
haracteristics).
iscussion
he  COLHYGE  study  has  shown  that  the  hypertensive  pop-
lation  medically  treated  by  cardiologists  in  France  is  a
igh-risk  population  with  a  high  prevalence  of  diabetes
ellitus  and  secondary  cardiovascular  prevention.  Only  a
inority  of  those  high-risk  hypertensives  had  controlled  BP,
art  of  this  lack  of  control  being  related  to  poor  compliancecteristics,  we  have  demonstrated  high  variability  among
hysicians  in  terms  of  BP  control,  only  partly  explained  by
he  physician  characteristics  assessed.
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Table  3  Relative  risk  of  not-at-goal  blood  pressure  according  to  patient  and  physician  characteristics  in  multivariable
analysis.
Variablesa Odds  ratiob [95  %  CI]  P
Patient  characteristics
Age  (per  12  years)  1.38  [1.26—1.50] <  0.001
Body  mass  index  (per  4.7  kg/m2)  1.12  [1.04—1.22] 0.005
Sex  (female  vs.  male)  1.00  [0.86—1.18] 0.753
Heart  rate  (per  11.8  bpm) 1.26  [1.16—1.37] <  0.001
Hypertension  duration  (<  1  vs.  >  10  years) 2.12  [1.52—2.96] <  0.001
Atrial  ﬁbrillation  (yes  vs.  no) 0.76  [0.62—0.93] 0.008
Left  ventricular  hypertrophy  (yes  vs.  no) 1.68  [1.39—2.04] < 0.001
Patient  belief  that  they  are  taking  too  many  pills 1.51  [1.20—1.91] < 0.001
Antihypertensive  treatment  characteristics
Calcium  channel  blockers  (yes  vs.  no) 1.53  [1.30—1.80] <  0.001
Centrally-acting  agents  1.90  [1.33—2.71] <  0.001
Renin-angiotensin  system  blockers  (yes  vs.  no)  0.74  [0.63—0.87] <  0.001
Fixed  combination  (yes  vs.  no)  0.66  [0.55—0.79] <  0.001
Other  treatment  characteristics
Antiplatelet  agents  (yes  vs.  no) 1.56 [1.29—1.88] < 0.001
Lipid-lowering  agents  (yes  vs.  no) 1.24  [1.04—1.48] 0.015
Physician  characteristics
City  size  (<  100,000  vs.  >  100,000  inhabitants)  1.30  [1.03—1.64] 0.027
Physician’s  exclusive  independent  practice  (yes  vs.  no)  0.73  [0.58—0.92] 0.008
bpm: beats per minute; CI: conﬁdence interval.
a For selection of variables, see statistical analysis section.
b Odds ratio calculated for one standard deviation unit increase in variables.
Table  4  Characteristics  of  the  linear  logistic  multilevel  model  (level  1  being  the  patient  level  and  level  2  the  physician
level).
Empty  model  Patient  model  Physician  model  Full  model
Median  odds  ratio 1.02  1.01  1.03  1.01
Q1—Q3  odds  ratio  0.64—1.48 0.65—1.45  0.65—1.45  0.69—1.39
Minimum—maximum  odds  ratio  0.14—3.06 0.14—2.86 0.15—2.94  0.18—2.64
Estimated  variance 0.78  0.76  0.75  0.68
Standard  deviation 0.10  0.10  0.09  0.09
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Several  characteristics  of  our  hypertensive  population
hould  be  pointed  out,  especially  the  high  rate  of  associated
ardiovascular  and  metabolic  diseases,  such  as  atrial  ﬁbril-
ation  (17.4%),  previous  atherothrombotic  events  (27.5%)  or
iabetes  mellitus  (22.8%).  Those  characteristics  are  much
ore  prevalent  than  in  general  hypertensive  populations
n  France  [1,2], although  comparison  is  methodologically
awed  because  of  the  different  recruitment  methods  used.
ther  characteristics  were  quite  unexpected,  such  as
he  high  prevalence  of  previous  antihypertensive-related
dverse  effects  (16.3%);  antihypertensives  are  quite  well
olerated  drugs,  but  modiﬁcation  of  drugs  over  the  years
nd  combinations  of  several  drugs  make  the  occurrence
f  adverse  effects  more  prevalent.  Such  events  should
e  anticipated,  as  they  have  been  shown  to  decrease
atient  conﬁdence  and  hence  treatment  compliance  [5].
oncerning  drug  treatment,  it  is  important  to  note  the
i
t
e.16  0.15  0.14
igh  rates  of  prescription  of  lipid-lowering  agents  (49.7%)
 mainly  statins  —  and  antihypertensive  ﬁxed  combina-
ions  (34.6%).  Comparison  of  the  prescription  rates  for
he  different  antihypertensive  drug  classes  is  difﬁcult  as
ome  classes  could  have  indications  other  than  hyper-
ension  in  this  high-cardiovascular-risk  population  (e.g.
eta-blockers  in  patients  with  coronary  heart  disease);
evertheless,  it  is  interesting  to  note  that  calcium  chan-
el  blockers  and  diuretics  were  the  agents  prescribed
ost  frequently  drugs  in  this  quite  elderly  population
mean  age,  66.5  years),  in  accordance  with  current  French
6]  and  European  guidelines  [4].  Despite  being  increas-
ngly  considered  as  second-line  drugs  in  hypertension  in
ecent  guidelines  [7],  beta-blockers  were  in  third  place
n  terms  of  prescription  rates  (42.7%),  in  accordance  with
he  high  prevalence  of  patients  with  coronary  heart  dis-
ase  (17.4%).  As  reported  in  previous  publications  [1],
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angiotensin  receptor  blockers  were  more  frequently  pre-
scribed  than  angiotensin-converting  enzyme  inhibitors  in
France.
Concerning  the  multivariable  analysis  of  not-at-goal  BP,
some  determinants  were  very  classical,  such  as  age,  being
overweight,  presence  of  left  ventricular  hypertrophy  and
prescription  of  antiplatelet  or  lipid-lowering  agents—these
last  two  determinants  probably  surrogates  of  secondary  car-
diovascular  prevention  (in  which  the  BP  goal  is  lower).  The
presence  of  atrial  ﬁbrillation  was  associated  with  better  BP
control  in  our  study  but  this  could  be  partly  explained  by
a  metrological  problem;  indeed,  BP  is  difﬁcult  to  measure
in  patients  with  atrial  ﬁbrillation,  with  possible  underes-
timation  of  real  BP  when  using  an  automated  BP  monitor.
Nevertheless,  a  recent  meta-analysis  reported  a  small  mean
underestimation  in  comparison  with  manual  BP  measure-
ment  (0.5  mmHg)  [8].  Other  determinants  seem  interesting
to  analyse:  namely,  the  prescription  of  a  ﬁxed  combination,
which  was  positively  associated  with  BP  control.  However,
because  the  number  of  antihypertensive  drugs  was  not  dif-
ferent  in  the  controlled  and  uncontrolled  BP  groups  (data
not  shown),  better  BP  control  in  patients  receiving  a  ﬁxed
combination  should  be  interpreted  in  terms  of  compliance;
the  greater  the  number  of  pills,  the  worse  the  compli-
ance  [9].  Similarly,  the  item:  ‘patient  belief  that  they
are  taking  too  many  pills’  is  probably  another  marker  of
poor  patient  compliance.  As  almost  half  of  the  patients
were  treated  with  beta-blockers,  the  positive  relationship
between  heart  rate  and  poor  BP  control  could  also  be  inter-
preted  as  a  marker  of  poor  compliance.  Although  its  role
cannot  be  quantiﬁed  in  the  present  study,  poor  compli-
ance  is  probably  a  major  determinant  of  BP  control  at  the
population  level,  as  recently  highlighted  in  the  PURE  study
[10].
Other  determinants  at  the  patient  level  are  difﬁcult  to
interpret  in  terms  of  causality.  For  example,  short  hyperten-
sion  duration  is  probably  associated  with  not  yet  optimized
treatment,  and  calcium  channel  blockers  and  centrally-
acting  agents  are  probably  more  frequently  prescribed  in
patients  with  resistant  hypertension.  Finally,  although  difﬁ-
cult  to  understand,  physician  characteristics  are  important
to  take  into  consideration  when  analysing  the  determinants
of  BP  control.  To  explain  the  better  BP  control  in  big  cities,
one  could  speculate  that  in  rural  regions  or  in  small  towns,
there  are  fewer  hypertension  reference  centres  that  could
help  in  terms  of  BP  control  in  resistant  hypertension.  We
also  found  that  exclusive  independent  practice  is  associated
with  better  BP  control  than  part-time  employee  activity.  We
could  imagine  that  cardiologists  who  also  work  in  clinics  or
hospitals  would  have  more  severe  patients  treated  in  their
ofﬁces,  explaining  the  poorer  control;  however,  because  this
association  persists  after  adjustment  for  patient  character-
istics,  this  ﬁnding  is  quite  mysterious  and  needs  further
investigation.
The  quantitative  characteristics  of  the  linear  logistic  mul-
tilevel  model  are  also  important  to  consider.  Indeed,  we
demonstrated  high  heterogeneity  among  the  physicians  in
terms  of  BP  control,  but  this  heterogeneity  was  independent
of  patient  characteristics.  As  the  high  intraclass  correla-
tion  shows  that  a  large  part  of  the  model  is  explained  by
physician  characteristics  that  were  not  taken  into  account
in  the  physician  questionnaire,  this  heterogeneity  could
l
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e related  to  physicians’  beliefs  concerning  optimal  BP
ontrol  in  different  hypertensive  subpopulations.  Indeed,
ome  recent  epidemiological  studies  focusing  on  therapeutic
nertia  reported  different  justiﬁcations  for  lack  of  treat-
ent  change  by  physicians  when  BP  was  not-at  goal.  In  a
ecent  French  study,  reluctance  to  rely  on  BP  measurements,
he  perception  that  guidelines  were  revised  frequently  and
ere  not  always  clear,  and  consideration  of  the  general
ractitioner’s  activity  in  the  patient’s  speciﬁc  context  were
he  main  reasons  for  therapeutic  inertia  in  general  practice
11].
These  original  results  need  to  be  further  explored  in  epi-
emiological  studies  focusing  on  determinants  of  BP  control,
n  order  to  deﬁne  possible  improvement  strategies  at  the
hysician  level.
tudy limitations
ur  study  was  limited  by  the  fact  that  the  panel  of  371
ardiologists  was  not  selected  randomly;  nevertheless,  the
anel  was  representative  of  the  French  cardiologist  popu-
ation  in  terms  of  the  main  characteristics  of  independent
ctivity.  Another  limitation  concerns  the  absence  of  a  simi-
ar  device  for  all  cardiologists  to  measure  BP;  this  probably
ntroduced  higher  variability  in  BP  measurements  and  then
odiﬁcations  in  the  relationship  between  BP  control  and
ts  determinants.  Nevertheless,  such  variability  should  have
ffected  controlled  and  uncontrolled  hypertensives  to  a  sim-
lar  extent,  leading  to  a simple  decrease  in  the  power  of  the
tatistical  analysis.  Concerning  inclusion  criteria  and  patient
haracteristics,  it  is  important  to  note  that  no  complemen-
ary  paraclinic  examination  was  mandatory.  Therefore,  it  is
ossible  that  patients  with  some  forms  of  undiagnosed  sec-
ndary  hypertension  were  included  and  that  undiagnosed
ssociated  conditions  were  missed  (silent  coronary  heart
isease,  etc.).  Furthermore,  it  is  possible  that  diagnos-
ic  criteria  differed  from  one  cardiologist  to  another  (e.g.
or  asymptomatic  peripheral  artery  disease  or  electrocar-
iographic  left  ventricular  hypertrophy).  As  patients  with
ndiagnosed  secondary  hypertension  have  a  higher  proba-
ility  of  being  uncontrolled,  this  could  have  modiﬁed  the
esults  of  the  multivariable  analysis  of  the  determinants  of
ncontrolled  hypertension.  Nevertheless,  because  the  inves-
igators  were  all  cardiovascular  specialists,  and  because
econdary  hypertension  is  quite  rare,  we  believe  that  this
ias  was  quite  modest.  Finally,  the  physicians  were  asked
ery  few  questions  about  their  practice;  as  a  result,  the
hysician  level  of  the  logistic  model  is  difﬁcult  to  anal-
se.
onclusion
n  conclusion,  the  COLHYGE  study  has  conﬁrmed  the  high
ardiovascular  risk  of  hypertensives  treated  by  their  car-
iologists  in  France.  Concerning  the  large  proportion  with
ncontrolled  BP,  numerous  determinants  were  pointed
ut:  namely,  classical  patient  characteristics,  including
ack  of  compliance,  but  also  physician  characteristics.
trategies  aimed  at  controlling  BP  at  the  population
evel  should  therefore  focus  on  both  patients  and  physi-
ians.
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